ClinicalTrials.govpublic full text
Study of Vorinostat (MK-0683) or Placebo, in Combination With Bortezomib in Participants With Multiple Myeloma (MK-0683-088 AMN)
multiple myeloma, neoplasms, plasma cell, neoplasms by histologic type, neoplasms, hemostatic disorders, vascular diseases, cardiovascular diseases, paraproteinemias, blood protein disorders, hematologic diseases, hemorrhagic disorders, lymphoproliferative disorders
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 869738
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.